Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Cell Prolif. 2020 Mar;53(3):e12761. doi: 10.1111/cpr.12761. Epub 2020 Feb 25.
Ferroptosis is a recently defined, non-apoptotic, regulated cell death (RCD) process that comprises abnormal metabolism of cellular lipid oxides catalysed by iron ions or iron-containing enzymes. In this process, a variety of inducers destroy the cell redox balance and produce a large number of lipid peroxidation products, eventually triggering cell death. However, in terms of morphology, biochemistry and genetics, ferroptosis is quite different from apoptosis, necrosis, autophagy-dependent cell death and other RCD processes. A growing number of studies suggest that the relationship between ferroptosis and cancer is extremely complicated and that ferroptosis promises to be a novel approach for the cancer treatment. This article primarily focuses on the mechanism of ferroptosis and discusses the potential application of ferroptosis in cancer therapy.
铁死亡是一种新近定义的、非细胞凋亡的、受调控的细胞死亡(RCD)过程,由铁离子或含铁酶催化的细胞脂质氧化物异常代谢所组成。在这个过程中,各种诱导剂破坏细胞氧化还原平衡并产生大量的脂质过氧化产物,最终导致细胞死亡。然而,从形态学、生物化学和遗传学角度来看,铁死亡与细胞凋亡、细胞坏死、自噬依赖性细胞死亡和其他 RCD 过程有很大的不同。越来越多的研究表明,铁死亡与癌症之间的关系极其复杂,铁死亡有望成为癌症治疗的新方法。本文主要聚焦于铁死亡的机制,并讨论了铁死亡在癌症治疗中的潜在应用。